Understanding Melanoma: Causes, Risk Factors, and Prevention

Melanoma is a malignant tumor originating from skin melanocytes, and its pathogenesis involves various complex interactions between biological and environmental factors. Research shows that while a small number of cases are directly related to genetic factors, the vast majority are the result of interactions between environmental influences and personal behaviors. Understanding these causes can help high-risk groups with prevention and provide scientific basis for clinical diagnosis and treatment strategies.

The development of this disease typically involves key steps such as the accumulation of DNA damage, uncontrolled cell proliferation, and failure of immune surveillance. DNA mutations caused by ultraviolet (UV) exposure are the primary triggering factors, but intrinsic conditions such as genetic predisposition and immune system status also play critical roles. These factors interact with each other, forming a multi-stage carcinogenic process, making the analysis of melanoma's causes necessary from multiple dimensions.

Genetic and Familial Factors

Abnormalities in genetic factors are significant risk factors for melanoma, with about 10% of patients having a family history. Mutations in the CDKN2A gene are particularly common; this gene is responsible for regulating the cell cycle and repairing DNA damage, and its defects lead to ineffective repair of UV-induced DNA damage. Other related genes such as BAP1 and CDK4 have also been found to be associated with familial melanoma, and these mutations may make the skin more sensitive to environmental carcinogens.

If multiple first-degree relatives (parents, siblings) in a family have this disease, an individual's risk may increase by 5-10 times. Certain specific populations, such as those with red hair and blue eyes, have MC1R gene polymorphisms that cause abnormal melanin synthesis, resulting in a weaker ability to repair UV damage. When this genetic background combines with environmental factors, the cancer risk increases exponentially.

  • Mutations in the CDKN2A gene lead to dysregulation of the cell cycle, accelerating malignant transformation.
  • In familial cases, patients often have an increased risk of other cancers (such as meningioma and pancreatic cancer).
  • Defects in the MC1R gene make melanocytes more sensitive to UV damage.

Environmental Factors

Ultraviolet (UV) exposure is the most evident environmental trigger for melanoma, with UV-B wavelengths (280-320 nm) directly damaging DNA and inducing the formation of thymine dimers. Accumulated damage that is not repaired can lead to mutations in tumor suppressor genes such as TP53, resulting in a loss of the ability to trigger apoptosis. Intermittent intense exposure (such as sunbathing) is more carcinogenic than prolonged uniform exposure, as this type of exposure is more likely to cause DNA double-strand breaks.

Geographical differences also highlight the critical role of environmental factors: the incidence rate in Australia and Northern Europe, where there is a high population of Caucasians, is significantly higher than in other regions, which is related to increased UV intensity due to proximity to the Antarctic ozone hole. Artificial sources of UV, such as tanning lamps and UV tanning devices, are also classified as Group 1 carcinogens by the World Health Organization, and their use is significantly associated with a decrease in the age of onset.

  • UV-B induced DNA damage: causes C to T transitions and thymine dimers.
  • Geographical distribution differences: incidence rates in the Southern Hemisphere's high-latitude regions are 30-50% higher than in the Northern Hemisphere at the same latitude.
  • Artificial UV exposure: tanning bed users have a 75% increased risk, and those under 35 years old have double the risk.

Lifestyle and Behavioral Factors

Individual UV protection habits directly affect the risk of developing the disease. A lack of daily sun protection measures (such as not using sunscreen with SPF 30 or higher, or not wearing sun-protective clothing) accelerates the accumulation of skin DNA damage. Outdoor workers or those who love outdoor activities, if they do not take proactive protection, have a melanoma risk 2-4 times higher than the general population.

The status of the immune system also influences the development of precancerous lesions. Organ transplant patients, due to long-term use of immunosuppressants, have a melanoma risk 2-3 times higher than the general population. Conversely, insufficient vitamin D intake may reduce the skin's immune surveillance ability, indirectly increasing cancer risk. Studies indicate that regular exercise can enhance natural killer cell activity, potentially reducing the likelihood of malignant transformation.

  • For every 10% decrease in sunscreen usage, the incidence rate increases by 15-20%.
  • Patients undergoing immunosuppressive therapy are recommended to have a full-body skin examination every 6 months.
  • Outdoor workers who do not wear long-sleeved clothing have a skin cancer risk 2.8 times higher than office workers.

Other Risk Factors

Skin type is an important biological marker, with Fitzpatrick classification type I (fair skin, prone to sunburn and difficult to tan) having a melanoma incidence rate over 50 times that of type V (dark skin). A history of severe sunburn, especially blistering sunburn during childhood, increases the risk by 83%. Additionally, chronic inflammatory environments are also associated with tumor development, as long-term skin ulcers or wounds may become origins of lesions.

Age is positively correlated with incidence, but specific risk patterns are observed among younger patients: a higher proportion of patients aged 20-39 have hereditary gene mutations. In terms of gender differences, male patients commonly have lesions on extremities, which is related to differences in skin type and UV exposure patterns. Patients with a history of chemotherapy or radiotherapy have an increased risk of secondary malignancy due to impaired DNA repair mechanisms, with a 2-3 times higher risk.

  • Individuals with skin type I have lower activity of DNA repair enzymes (such as XPE).
  • Patients post-chemotherapy need to undergo full-body skin imaging screening every 3 years.
  • Extremity melanoma has a relatively higher incidence in dark-skinned populations.

The interaction of the above multiple factors forms a complex carcinogenic network: genetic susceptibility reduces the ability to repair cells, environmental exposure provides carcinogenic stimuli, and defects in immune surveillance hinder the clearance of early abnormal cells. The cumulative effect of these factors explains why some patients still develop the disease in relatively low UV exposure environments. The development of precision medicine is promoting the establishment of personalized risk assessment systems through gene sequencing and tracking environmental exposure.

Prevention strategies need to target different levels of risk factors: genetic counseling and gene screening can be used for high-risk families, environmental protection measures (such as sun protection behaviors) can block key carcinogenic pathways, and immunomodulatory therapies may become a new direction for early intervention in the future. Understanding these causal networks helps establish a more effective holistic health management system.

 

Frequently Asked Questions

How to perform a self-examination for melanoma? What skin changes should be noted?

During self-examination, one should observe whether moles or spots on the skin exhibit "asymmetry" (uneven size, color, shape), whether the borders are blurred, whether the colors are mixed (such as black, brown, red), whether the diameter exceeds 6 mm, or whether the shape changes rapidly over time. It is recommended to check the entire body at a fixed time each month under natural light and record any abnormal changes for tracking.

If melanoma has metastasized to other organs, how does the treatment differ?

When melanoma metastasizes, treatment primarily involves systemic therapies, including immunotherapy (such as using anti-PD-1 monoclonal antibodies) or targeted therapy (drugs targeting gene mutations). In certain cases, surgery or radiation therapy may be combined to control symptoms. Treatment plans should be formulated by an oncologist based on staging and genetic testing results.

Besides applying sunscreen, what additional protective measures are there for daily sun protection?

Avoid prolonged exposure during high UV index periods (such as from 10 AM to 2 PM), and wear wide-brimmed hats, long-sleeved clothing, and UV-protective clothing. Use broad-spectrum sunscreen with SPF 30 or higher, reapply every 2 hours, and combine with physical shielding measures to reduce the risk of UV damage. The blue light from electronic screens does not directly induce melanoma, but prolonged exposure to artificial light sources with UV should be noted.

For those with a family history of melanoma, how to assess personal risk and conduct regular screenings?

Those with a family history should undergo professional skin examinations every 3-6 months and inform their physician of their family history to assess genetic risk. If specific gene mutations such as CDKN2A are found, closer monitoring plans can be developed through genetic counseling. It is essential to strictly avoid sunburns in daily life and pay attention to any new growths or changes in existing moles on the body.

Is the common misconception that "dark-skinned individuals are less likely to develop melanoma" correct?

This statement is not entirely correct. While skin pigmentation can partially block UV rays, dark-skinned individuals can still develop melanoma due to genetic mutations or chronic damage, often occurring on extremities (such as palms and soles). Physicians recommend that all populations should be vigilant for abnormal skin changes and not neglect examinations simply because of darker skin, especially paying attention to changes in non-sun-exposed areas.

Melanoma